Evidence-Based Complementary and Alternative Medicine

Recently Published Articles

Irisin Activates M1 Macrophage and Suppresses Th2-Type Immune Response in Rats with Pelvic Inflammatory Disease, Zhenge Zhang, Chongyuan Zhang, and Shuirong Zhang Volume 2022 (2022), Article ID 5215915, 7 pages

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Wen-Yu-Jin against Pulmonary Fibrosis in a Mouse Model, Lu Wang, Wenxiang Zhu, Rui Sun, Jing Liu, Qihong Ma, Binbin Zhang, and Yuanyuan Shi Volume 2022 (2022), Article ID 7753508, 16 pages

Network Pharmacology Combined with Molecular Docking and Experimental Verification Reveals the Bioactive Components and Potential Targets of Danlong Dingchuan Decoction against Asthma, Beibei Xue, Qingyang Zhao, Di Chen, Xia Wang, Lanxuan Li, Jianbao Li, and Jinna Tian Volume 2022 (2022), Article ID 7895271, 15 pages

Research Progress on the Pharmacological Action of Schisantherin A, Zehao Xiao, Wen Xiao, and Guilin Li Volume 2022 (2022), Article ID 6420865, 11 pages

Effect of Shenling Baizhu San on Intestinal Flora in a Rat Model of Ulcerative Colitis with Spleen Deficiency and Dampness, Yiting Luo, Fangyuan Zhu, Jiaqian Wu, Jin Wu, Pei Wu, and Yingchao Liu Volume 2022 (2022), Article ID 9985147, 24 pages

Mechanism of Synsepalum dulcificum Daniell. Inhibiting Lung Adenocarcinoma, Qi Chen, Tingting Liu, Tuya Bai, Mengdi Zhang, Yuxia Hu, Jun Li, and Fuhou Chang Volume 2022 (2022), Article ID 5242179, 30 pages

Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway, Ying Li, Haitao Tu, Yan Luo, Weijian Xiong, Hong Liu, Yanying Xiong, Qin Zhang, Huihui Li, and Xuan Gao Volume 2022 (2022), Article ID 3754985, 10 pages

Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study, Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M. R. Hussain, and Shams Tabrez Volume 2022 (2022), Article ID 6224666, 10 pages

BushenHuoxue Recipe for the Treatment of Prethrombotic State of ACA-Positive Recurrent Miscarriage via the Regulation of the PI3K-AKT Signaling Pathway, Xuan Yang, Shulan Su, Qingling Ren, Lijing Liu, Jiashang Li, Wen Zhang, Ke Cai, Zhuo Xu, and Xin Pan Volume 2022 (2022), Article ID 2385534, 16 pages

Electroacupuncture Alleviates Visceral Hypersensitivity in IBS-D Rats by Inhibiting EGCs Activity through Regulating BDNF/TrkB Signaling Pathway, Ying Zhao, Hui-ling Jiang, Yu Shi, Wei Zhang, Lei-xiao Zhang, Yu-jun Hou, Zuo-qin Yang, Bao-yu He, Fan-rong Liang, and Qian-hua Zheng Volume 2022 (2022), Article ID 2497430, 11 pages

Mechanisms of Vitamin C Regulating Immune and Inflammation Associated with Neonatal Hypoxic-Ischemic Encephalopathy Based on Network Pharmacology and Molecular Simulation Technology, Shangbin Li, Shuangshuang Li, Qian Zhao, Jiayu Huang, Jinfeng Meng, Weichen Yan, Jie Wang, Changjun Ren, and Ling Hao Volume 2022 (2022), Article ID 4904325, 16 pages

The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis, Yang Cao, Mi Zhou, Min Tian, and Hong-bin Lv Volume 2022 (2022), Article ID 3156503, 11 pages

Treatment of Liver Cancer: Role of the Traditional Mongolian Medicine, Xiaomei Bao, Lu Chen, Yiman Liu, Hua Sheng, Kailong Wang, Yanming Luo, Tongling Qin, Ying Liu, and Yuling Qiu Volume 2022 (2022), Article ID 6535977, 18 pages

Best regards, The Evidence-Based Complementary and Alternative Medicine team ecam@hindawi.com Hindawi Limited Hindawi.com | Twitter | Facebook | LinkedIn | YouTube

Hindawi Limited, Adam House, Third Floor 1 Fitzroy Square, London W1T 5HF, UK www.hindawi.com

You have received this email to evidencehub.evidencehub@blogger.com from Evidence-Based Complementary and Alternative Medicine (published by Hindawi Limited, company number: 08671628, with registered address: Adam House, Third Floor, 1 Fitzroy Square, London, W1T 5HF, UK) because you have actively signed up to receive content alerts from Evidence-Based Complementary and Alternative Medicine. Hindawi respects your right to privacy and will not disclose your email address to any third parties without your consent. To see the types of information we may hold or collect about you and how we may use that information, please see our Privacy Policy. If you would prefer not to receive any further messages from Evidence-Based Complementary and Alternative Medicine or Hindawi, please contact Privacy@hindawi.com or click here to unsubscribe from the alert mailing list.